Table 1.
Parameters | Total No. of Subjects (n=1200) |
Males | P | Females | P | ||
MetS (n=258) |
Non-MetS (n=224) |
MetS (n=490) |
Non-MetS (n=228) |
||||
Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||
Age (years) | 49.74±11.07 | 55.3±6.9 | 42.6±10.1 | .001 | 55.5±6.9 | 38.0±9.6 | .001 |
BMI (kg/m2) | 30.22±6.28 | 31.1±4.5 | 25.0±3.6 | .001 | 34.2±5.9 | 25.4±3.4 | .001 |
Central obesity | 985 (82.08%) | 258 (100%) | 57 (25.4%) | .001 | 490 (100%) | 180 (78.9%) | .001 |
High BP | 771 (64.25%) | 250 (96.8%) | 39 (17.4%) | .001 | 481 (98.1%) | 1 (0.4%) | .001 |
High triglycerides | 504 (42%) | 154 (59.6%) | 8 (3.5%) | .001 | 341 (69.5%) | 1 (0.4%) | .001 |
Low HDL-c | 487 (40.58%) | 138 (53.4%) | 8 (3.5%) | .001 | 340 (69.3%) | 1 (0.4%) | .001 |
In our study, all participants previously diagnosed T2DM |
Central obesity was defined as waist circumference ≥ 94 cm in men and ≥ 80 cm in women. High blood pressure was ≥ 130/85 mmHg or treatment of previously diagnosed hypertension. High triglyceride was ≥150 mg/dl or specific treatment for this lipid abnormality. Low high-density lipoprotein cholesterol was <40 mg/dl in males and <50 mg/dl in females or specific treatment for this lipid abnormality.
The differences between means were tested by using independent sample t test. Descriptive statistics, Crosstabs, the chi-square test were used to examine difference in the prevalence of different categorical variables. P value less than 0.05 was considered as statistically significant.